Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
國立臺灣大學
/
醫學院
/
皮膚科
TSEN-FANG TSAI
研究人員網路
瀏覽統計
Email 通知
RSS Feed
簡歷
研究成果
371
計畫
11
研究成果
(全部)
全部
期刊文章
回顧型論文
會議論文
其他
顯示/隱藏過濾條件
依作者
25
tsen-fang tsai
10
hsien-yi chiu
7
wang t.-s.;tsen-fang tsai
2
hsieh c.-f.
2
tsai y.-c.
1
chang c.-y.
1
chen k.-l.
1
cheng y.-p.
1
chia-yu chu
1
chiang y.-t.
.
下一頁 >
主題
15
[sdgs]sdg3
1
15 hydroxyicosatetraenoic acid; adalimumab; alefacept; aminolevulinic acid; aminophylline; antiinflammatory agent; bevacizumab; bleomycin; botulinum toxin a; corticosteroid; cyclosporin; etanercept; etretin; fluorouracil; methotrexate; mitomycin; pentoxifylline; rituximab; vinblastine; vincristine; ankylosing arthritis; arthritis; chemotherapy; drug efficacy; drug megadose; drug potentiation; human; intralesional drug administration; low drug dose; nail psoriasis; priority journal; psoriasis; psoriatic arthritis; review; rheumatoid arthritis; treatment duration; dermatologic agents; humans; injections, intralesional; psoriasis
1
adalimumab; adefovir dipivoxil; efalizumab; etanercept; lamivudine; methotrexate; adult; arthralgia; article; clinical article; disease severity; drug dose sequence; drug efficacy; drug safety; drug substitution; drug withdrawal; female; human; liver function test; loading drug dose; male; nevus; outcome assessment; psoriasis; psoriasis area and severity index; retrospective study; side effect; treatment response; unspecified side effect
1
adalimumab; alanine aminotransferase; efalizumab; etanercept; etretin; methotrexate; acne; adolescent; adult; aged; alanine aminotransferase blood level; alopecia areata; bacterial endocarditis; cellulitis; child; colon cancer; dermatology life quality index; disease severity; dizziness; drug efficacy; drug safety; drug substitution; drug tolerability; drug withdrawal; eczema; extrapulmonary tuberculosis; female; fever; flu like syndrome; folliculitis; gingivitis; headache; health care financing; herpes labialis; herpes zoster; human; hyperglycemia; injection site reaction; lymphoma; major clinical study; male; paronychia; physician global assessment; priority journal; pruritus; psoriasis; quality of life; reimbursement; remission; retrospective study; review; scoring system; side effect; stroke; subject global assessment; systemic therapy; treatment response; urticaria; weakness; antibodies, monoclonal, humanized; humans; insurance coverage; psoriasis; retrospective studies; severity of illness index; taiwan
1
adalimumab; corticosteroid; etretin; etretinate; ustekinumab; abdomen; acrodermatitis continua; adult; back; case report; disease duration; disease exacerbation; drug withdrawal; fever; finger; forearm; hand; human; hyperlipidemia; injection site erythema; leg; letter; male; middle aged; priority journal; psoriasis; psoriatic plaque; pustular psoriasis; pustule; relapse; skin; skinfold; systemic therapy; anti-inflammatory agents; antibodies, monoclonal, humanized; disease progression; humans; injections; male; middle aged; psoriasis
1
adalimumab; etanercept; isoniazid; methotrexate; tuberculostatic agent; ustekinumab; dermatological agent; gamma interferon; ustekinumab; adult; article; disease burden; female; follow up; human; latent tuberculosis; long term care; major clinical study; male; mycobacterium tuberculosis test kit; prescription; prevalence; psoriasis; retrospective study; screening test; seroconversion; taiwan; treatment outcome; treatment response; university hospital; blood; combination drug therapy; complication; interferon gamma release assay; latent tuberculosis; middle aged; procedures; psoriasis; tuberculin test; adult; dermatologic agents; drug therapy, combination; female; humans; interferon-gamma; interferon-gamma release tests; latent tuberculosis; male; middle aged; psoriasis; retrospective studies; treatment outcome; tuberculin test; ustekinumab
1
adult; aged; allergic rhinitis; alopecia areata; article; asthma; case control study; chronic obstructive lung disease; cohort analysis; comorbidity; controlled study; crohn disease; depression; diabetes mellitus; digestive system cancer; disease association; disease severity; fatty liver; female; heart disease; hepatitis b; hepatitis c; human; hyperglycemia; hypertension; lip cancer; major clinical study; male; mouth cancer; pemphigoid; pemphigus; peritoneum cancer; pharynx cancer; prevalence; priority journal; psoriasis; rheumatoid arthritis; risk factor; sleep disorder; systemic lupus erythematosus; taiwan; vitiligo; adult; age distribution; aged; ambulatory care; case-control studies; comorbidity; databases as topic; female; humans; logistic models; male; middle aged; national health programs; patient admission; prevalence; proportional hazards models; psoriasis; risk assessment; risk factors; severity of illness index; sex distribution; taiwan; young adult
1
adult; arthritis; article; cardiovascular disease; cardiovascular risk; cerebrovascular accident; cohort analysis; controlled study; data base; disease severity; human; ischemic heart disease; major clinical study; proportional hazards model; psoriasis; retrospective study; sleep disorder; taiwan; adolescent; aged; complication; factual database; female; male; middle aged; myocardial ischemia; pathology; psoriasis; severity of illness index; sleep disorder; young adult; adolescent; adult; aged; arthritis; cohort studies; databases, factual; female; humans; male; middle aged; myocardial ischemia; proportional hazards models; psoriasis; severity of illness index; sleep wake disorders; young adult
1
azathioprine; inorganic pyrophosphatase; inosine triphosphate; inosine triphosphate pyrophosphatase; thiopurine methyltransferase; unclassified drug; abdominal pain; adult; allele; arthralgia; article; blood toxicity; chinese; comparative study; controlled study; diarrhea; disease association; drug dose increase; enzyme polymorphism; fatigue; female; genetic screening; genotype; human; hypertransaminasemia; leukopenia; liver toxicity; major clinical study; male; middle aged; nausea; neutropenia; pancreatitis; pancytopenia; pruritus; rash; thrombocytopenia; vomiting
1
clobetasol propionate; methotrexate; prednisolone; rituximab; absence of side effects; aged; article; bullous pemphigoid; case report; disease duration; drug efficacy; drug safety; drug withdrawal; human; immunofluorescence test; long term care; low drug dose; male; osteoporosis; papilledema; phototherapy; priority journal; pruritus; psoriasis vulgaris; remission; skin atrophy; skin biopsy; trunk; ultraviolet b radiation; urticaria; aged, 80 and over; anti-inflammatory agents; antibodies, monoclonal, murine-derived; drug therapy, combination; humans; immunologic factors; immunosuppressive agents; induction chemotherapy; male; methotrexate; pemphigoid, bullous; prednisolone; psoriasis
.
下一頁 >
依日期
1
2020 - 2021
24
2010 - 2019
依類型
8
journal article
8
journal article
3
letter
3
review
2
review
1
letter
全文
25
no fulltext
關閉過濾條件
再查詢
作者:
wang t.-s.
第 1 到 25 筆結果,共 25 筆。
公開日期
標題
作者
來源出版物
scopus
WOS
全文
1
2021
Correlation of clinical diagnosis of dactylitis by the dermatologist and ultrasonographic diagnosis by the rheumatologist in patients with psoriasis arthritis: Experience of a single clinic
Lo Y.; Wang T.-S.; KO-JEN LI
; TSEN-FANG TSAI
Dermatologica Sinica
3
2
2
2019
Human leukocyte antigen and demographic characteristics in Chinese patients with active peripheral type psoriatic arthritis who had inadequate response to conventional disease-modifying antirheumatic drugs in a single dermatologic clinic
Sin C.-Z.; Wang T.-S.; HSIEN-YI CHIU
; TSEN-FANG TSAI
PLoS ONE
8
6
3
2019
Biologics switch in psoriasis
Wang T.-S.; TSEN-FANG TSAI
Immunotherapy
17
19
4
2018
Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study
HSIEN-YI CHIU
; Hui R.C.-Y.; Huang Y.-H.; Huang R.-Y.; Chen K.-L.; Tsai Y.-C.; Lai P.-J.; Wang T.-S.; TSEN-FANG TSAI
Acta Dermato-Venereologica
56
45
5
2018
Psoriasis in Taiwan: From epidemiology to new treatments
HSIEN-YI CHIU
; Wang T.-S.; PO-HUA CHEN
; Hsu S.-H.; Tsai Y.-C.; TSEN-FANG TSAI
Dermatologica Sinica
36
35
6
2018
Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series
Weng H.-J.; Wang T.-S.; TSEN-FANG TSAI
British Journal of Dermatology
33
31
7
2017
Tofacitinib in psoriatic arthritis
Wang T.-S.; TSEN-FANG TSAI
Immunotherapy
8
5
8
2017
Managing Scalp Psoriasis: An Evidence-Based Review
Wang T.-S.; TSEN-FANG TSAI
American Journal of Clinical Dermatology
27
19
9
2017
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
Hsiao C.-Y.; HSIEN-YI CHIU
; Wang T.-S.; TSEN-FANG TSAI
PLoS ONE
25
21
10
2016
Epidemiology of psoriatic disease and current treatment patterns from 2003 to 2013: A nationwide, population-based observational study in Taiwan
Wang T.-S.; Hsieh C.-F.; TSEN-FANG TSAI
Journal of Dermatological Science
33
33
11
2016
Concomitant sleep disorders significantly increase the risk of cardiovascular disease in patients with psoriasis
HSIEN-YI CHIU
; Hsieh C.-F.; Chiang Y.-T.; Tsai Y.-W.; Huang W.-F.; Li C.-Y.; Wang T.-S.; TSEN-FANG TSAI
PLoS ONE
27
17
12
2015
Development of lichen striatus in a psoriasis patient treated with adalimumab
Lin I.-C.; Wang T.-S.; HSIEN-YI CHIU
; TSEN-FANG TSAI
Dermatologica Sinica
1
2
13
2015
Practical experience of ustekinumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to previous tumor necrosis factor blockers
Wang T.-C.; HSIEN-YI CHIU
; Wang T.-S.; TSEN-FANG TSAI
Dermatologica Sinica
16
16
14
2014
Psoriasis sparing the lower limb with postpoliomyelitis residual paralysis
Wang T.-S.; TSEN-FANG TSAI
The British journal of dermatology
13
9
15
2014
Cutaneous irritancy of water
Wang T.-S.; TSEN-FANG TSAI
Reviews on Environmental Health
3
0
16
2014
Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients
Wang T.-S.; HSIEN-YI CHIU
; Wu L.S.-H.; CHIA-YU CHU
; TSEN-FANG TSAI
Dermatologica Sinica
9
8
17
2014
Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: A retrospective analysis
HSIEN-YI CHIU
; Wang T.-S.; CHIH-CHIEH CHAN
; Cheng Y.-P.; SUNG-JAN LIN
; TSEN-FANG TSAI
British Journal of Dermatology
69
67
18
2014
Occurrence of psoriatic plaques on previous adalimumab injection sites during disease relapse in a patient with pustular psoriasis
Wang T.-S.; TSEN-FANG TSAI
Journal of the American Academy of Dermatology
3
3
19
2014
Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low dose methotrexate
Wang T.-S.; TSEN-FANG TSAI
Acta Dermato-Venereologica
14
11
20
2013
Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept
Wang T.-S.; TSEN-FANG TSAI
Dermatologica Sinica
12
13
21
2013
Isolated erythematous plaque on the right cheek
Wang T.-S.; TSEN-FANG TSAI
Dermatologica Sinica
0
0
22
2013
Intralesional therapy for psoriasis
Wang T.-S.; TSEN-FANG TSAI
Journal of Dermatological Treatment
12
11
23
2012
The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis
HSIEN-YI CHIU
; Wang T.-S.; Chang C.-Y.; TSEN-FANG TSAI
Journal of the European Academy of Dermatology and Venereology
17
17
24
2011
Clinical experience of ustekinumab in the treatment of erythrodermic psoriasis: A case series
Wang T.-S.; TSEN-FANG TSAI
Journal of Dermatology
35
30
25
2011
Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan
TSEN-FANG TSAI
; Wang T.-S.; Hung S.-T.; Tsai P.I.C.; Schenkel B.; Zhang M.; Tang C.-H.
Journal of Dermatological Science
249
234
申請連結研究人員資料
以 ORCID 登入申請連結此個人資料
ORCID Login
Contact via feedback form
若您要聯絡網站管理員,請點選以下按鈕